» Articles » PMID: 32577833

Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey

Overview
Publisher Current Science
Specialty Rheumatology
Date 2020 Jun 25
PMID 32577833
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the prevalence of overweight and obesity, as well as the association between body mass index (BMI) and disease activity in patients with axial spondyloarthritis (axSpA).

Methods: Norwegian axSpA patients from the European Map of Axial Spondyloarthritis (EMAS) survey were included in this analysis. Sociodemographic, anthropomorphic, and disease-related variables (HLA-B27, comorbidities, BASDAI, and self-reported spinal stiffness) were reported. Patients were categorized into under/normal weight (BMI < 25 kg/m), overweight (BMI ≥ 25 to < 30 kg/m), and obese (≥ 30 kg/m).

Results: Of the 509 participants in the EMAS survey, 35% were categorized as under/normal weight, 39% overweight, and 26% obese. Compared to under/normal-weight patients, overweight patients had significantly higher degree of spinal stiffness (mean (SD) 7.91 ± 2.02 vs 7.48 (2.15) and number of comorbidities (2.45 ± 2.11, vs 1.94), both p < 0.001. Obese patients had significantly higher disease activity (BASDAI mean (SD) 5.87 ± 1.78 vs 4.99 ± 2.08, p < 0.001), degree of spinal stiffness (8.18 ± 2.03 vs 7.48 ± 2.15, p = 0.006), and number of comorbidities (3.43 ± 2.43 vs 1.94. ± .38, p < 0.001) than under/normal weight patients. After adjusting for gender and age, obesity proved to be independently associated with disease activity.

Conclusion: Obesity was associated with higher reported BASDAI score, and being overweight or obese was associated with a higher degree of spinal stiffness and number of comorbidities compared to under/normal weight respondents. The results highlight the serious impact of obesity on health status, and obesity should therefore be considered as a modifiable risk factor for disease activity within the disease management of axSpA.

Citing Articles

Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis.

Corrado A, Guadagni I, Picarelli G, Variola A Immun Inflamm Dis. 2025; 13(1):e70080.

PMID: 39760506 PMC: 11702394. DOI: 10.1002/iid3.70080.


Do the Activity Indices Used in Axial Spondyloarthritis Capture the Relationships Between Obesity, Smoking and Disease Activity in the Same Way?.

Queiro R, Alonso-Castro S, Brana I, Loredo M, Pardo E, Burger S J Clin Med. 2024; 13(22).

PMID: 39597945 PMC: 11594675. DOI: 10.3390/jcm13226801.


Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS).

Makan K, Garrido-Cumbrera M, Du Toit R, Correa-Fernandez J, van Dam M, Tikly M Clin Rheumatol. 2024; 43(11):3335-3343.

PMID: 39333345 PMC: 11489170. DOI: 10.1007/s10067-024-07151-8.


International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe.

Garrido-Cumbrera M, Poddubnyy D, Sommerfleck F, Bundy C, Makri S, Correa-Fernandez J RMD Open. 2024; 10(2).

PMID: 38851236 PMC: 11163687. DOI: 10.1136/rmdopen-2023-003504.


Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with.

Iyer P, Hwang M, Ridley L, Weisman M RMD Open. 2023; 9(4).

PMID: 37949613 PMC: 10649803. DOI: 10.1136/rmdopen-2023-003372.


References
1.
Perandini L, de Sa-Pinto A, Roschel H, Braga Benatti F, Rodrigues Lima F, Bonfa E . Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmun Rev. 2012; 12(2):218-24. DOI: 10.1016/j.autrev.2012.06.007. View

2.
Halvorsen S, Vollestad N, Provan S, Semb A, van der Heijde D, Hagen K . Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative study. Arthritis Care Res (Hoboken). 2013; 65(6):969-76. PMC: 3619024. DOI: 10.1002/acr.21926. View

3.
Mason J, Libby P . Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2014; 36(8):482-9c. PMC: 4340364. DOI: 10.1093/eurheartj/ehu403. View

4.
Lee D, Artero E, Sui X, Blair S . Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol. 2010; 24(4 Suppl):27-35. PMC: 2951585. DOI: 10.1177/1359786810382057. View

5.
Fischer C . Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc Immunol Rev. 2007; 12:6-33. View